181 related articles for article (PubMed ID: 27445288)
1. Nuclear Medicine in Cancer Theranostics: Beyond the Target.
Taïeb D; Hicks RJ; Pacak K
J Nucl Med; 2016 Nov; 57(11):1659-1660. PubMed ID: 27445288
[No Abstract] [Full Text] [Related]
2. Nuclear medicine theranostics comes of age.
Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
[No Abstract] [Full Text] [Related]
3. [PET/CT: Molecular Imaging and Theranostics for Radionuclide Therapy].
Derlin T; Bengel FM
Pneumologie; 2017 Jan; 71(1):48-62. PubMed ID: 28114710
[No Abstract] [Full Text] [Related]
4. Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.
Turner JH
Cancer Biother Radiopharm; 2019 Apr; 34(3):135-140. PubMed ID: 30973278
[No Abstract] [Full Text] [Related]
5. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
6. Bioinspired approaches for cancer nanotheranostics.
Evangelopoulos M; Tasciotti E
Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
[No Abstract] [Full Text] [Related]
7. Production and purification of Scandium-47: A potential radioisotope for cancer theranostics.
Deilami-Nezhad L; Moghaddam-Banaem L; Sadeghi M; Asgari M
Appl Radiat Isot; 2016 Dec; 118():124-130. PubMed ID: 27640172
[TBL] [Abstract][Full Text] [Related]
8. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
9. Theranostic and nanotheranostic probes in nuclear medicine.
Drude N; Tienken L; Mottaghy FM
Methods; 2017 Nov; 130():14-22. PubMed ID: 28698069
[TBL] [Abstract][Full Text] [Related]
10. Theranostic Probes for Cancer Imaging.
Wang F; Zhu L; Yang K; Park D
Contrast Media Mol Imaging; 2017; 2017():1863803. PubMed ID: 29114172
[No Abstract] [Full Text] [Related]
11. Highlights from 2017: impactful topics published in the Annals of Nuclear Medicine.
Farolfi A; Ghedini P; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):217-223. PubMed ID: 30267115
[TBL] [Abstract][Full Text] [Related]
12. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J
J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
[No Abstract] [Full Text] [Related]
13. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].
Schaefer N; Prior J
Ther Umsch; 2019 Sep; 76(4):167-172. PubMed ID: 31498036
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Imaging Enters a New Era: Combining Diagnosis and Therapy, Nuclear Medicine Has the Potential to Advance Cancer Treatment and Care.
Mertz L
IEEE Pulse; 2018; 9(2):4-8. PubMed ID: 29553932
[TBL] [Abstract][Full Text] [Related]
16. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
17. Invited Commentary: Nuclear Theranostics-The Path Forward.
Greenspan BS; Jadvar H
Radiographics; 2020 Oct; 40(6):1741-1742. PubMed ID: 33016813
[No Abstract] [Full Text] [Related]
18. Companion Diagnostics and Molecular Imaging.
Puranik AD; Kulkarni HR; Baum RP
Cancer J; 2015; 21(3):213-7. PubMed ID: 26049701
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in carbon based nanosystems for cancer theranostics.
Augustine S; Singh J; Srivastava M; Sharma M; Das A; Malhotra BD
Biomater Sci; 2017 May; 5(5):901-952. PubMed ID: 28401206
[TBL] [Abstract][Full Text] [Related]
20. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
Hajba L; Guttman A
Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
